Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. (LFCR) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LFCR · as of Sep 30, 2025
Ownership Breakdown
101
Institutional Holders
▲ 14 vs Q2
$199.25M
Total Inst. Value
▼ $21.38M vs Q2
37.51M
Shares Outstanding
freeFloat 91.12%
24.34M
13F Shares Held
▼ 313,078 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LFCR largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
WYNNEFIELD CAPITAL INC pharmaceutical preparations | 4.70M | 12.70% | 12.70% | $34.62B | Nov 14, 2025 | — held |
LEGION PARTNERS ASSET MANAGEMENT, LLC pharmaceutical preparations | 4.46M | 12.05% | 12.05% | $32.84B | Nov 14, 2025 | ▲ 30.0K |
GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P. pharmaceutical preparations | 3.69M | 9.98% | 9.98% | $27.19B | Dec 1, 2025 | — held |
325 CAPITAL LLC pharmaceutical preparations | 2.16M | 5.84% | 5.84% | $15.92B | Nov 14, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 1.84M | 4.97% | 4.97% | $13.55B | Nov 12, 2025 | ▼ 34.2K |
VANGUARD GROUP INC pharmaceutical preparations | 1.62M | 4.38% | 4.38% | $11.94B | Nov 7, 2025 | ▲ 12.9K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 773.6K | 2.09% | 2.09% | $5.70B | Nov 12, 2025 | ▼ 1.9K |
GRIZZLYROCK CAPITAL, LLC pharmaceutical preparations | 738.9K | 2.00% | 2.00% | $5.44B | Nov 14, 2025 | ▲ 4.3K |
MORGAN STANLEY pharmaceutical preparations | 709.7K | 1.92% | 1.92% | $5.22B | May 27, 2026 | ▼ 30.1K |
STATE STREET CORP pharmaceutical preparations | 539.3K | 1.46% | 1.46% | $3.97B | Nov 14, 2025 | ▲ 8.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
18
Increased
+479.8K shares6
New Positions
first time holders17
Decreased
−271.0K shares0
Sold Out
fully exitedNet shares change (top 50)
+208.8K
+479.8K / −271.0K
Net new holders
+7
6 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LFCR insider trading · insider activity
Source: SEC Form 4
7
Buy transactions
2
Sell transactions
3.50
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Kiper Christopher S
| Jun 4, 2026 | Award | 25,907 | — | — | 103.5K | Form 4 ↗ |
OBUS NELSON director | Jun 4, 2026 | Award | 25,907 | — | — | 164.1K | Form 4 ↗ |
Aryeh Jason director | Jun 4, 2026 | Award | 25,907 | — | — | 70.0K | Form 4 ↗ |
Schechter Joshua director | Jun 4, 2026 | Award | 25,907 | — | — | 133.1K | Form 4 ↗ |
Korenberg Matthew E director | Jun 4, 2026 | Award | 25,907 | — | — | 70.0K | Form 4 ↗ |
Antunes Humberto Calheiros director | Jun 4, 2026 | Award | 25,907 | — | — | 73.0K | Form 4 ↗ |
Johnson Paul Harold director | Jun 4, 2026 | Award | 25,907 | — | — | 70.0K | Form 4 ↗ |
HOUDE LOVAS KATRINA director | Jun 4, 2026 | Award | 25,907 | — | — | 135.3K | Form 4 ↗ |
Josephs Paul Chief Executive Officer | May 20, 2026 | Tax Withhold | 40,413 | $4.57 | $184.7K | 592.9K | Form 4 ↗ |
Salus Thomas D. Chief Legal & Administration | Apr 14, 2026 | Tax Withhold | 24,645 | $5.20 | $128.2K | 246.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Lifecore Biomedical, Inc. (LFCR) is primarily owned by institutional investors, who hold approximately 64.9% of total shares outstanding. Company insiders own approximately 8.88%, while retail and public investors account for the remaining 26.24%.
The largest institutional shareholder of Lifecore Biomedical, Inc. is WYNNEFIELD CAPITAL INC, holding approximately 4.70 million shares — equal to 12.70% of outstanding shares — as of September 30, 2025.
A total of 101 institutional investors currently hold LFCR stock, with a combined institutional value of approximately $199,252,120 as of the most recent 13F filing period.
Frequently asked questions
LFCR ownershipLifecore Biomedical, Inc. (LFCR) is primarily owned by institutional investors, who hold approximately 64.9% of shares. The largest shareholder is WYNNEFIELD CAPITAL INC with a 12.70% stake. Company insiders hold 8.88%. Data sourced from SEC Form 13F as of September 30, 2025.